Cellebrite DI Ltd. Class A Ordinary Shares (CLBT) is a publicly traded Technology sector company. As of November 5, 2026, CLBT trades at $12.51 with a market cap of $3.08B and a P/E ratio of 0.00. CLBT moved +0.68% today. Year to date, CLBT is -31.12%; over the trailing twelve months it is -21.77%. Its 52-week range spans $9.58 to $20.86. Analyst consensus is strong buy with an average price target of $14.58. Rallies surfaces CLBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CLBT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $12.51 |
| Market Cap | $3.08B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.86 |
| 52-Week Low | $9.58 |
| Volume | 63.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover CLBT: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.58.